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Molecular Studies of Phenotype Variation in Canine RPGR-XLPRA1
Abstract
Purpose
Purpose: Canine X-linked progressive retinal atrophy 1 (XLPRA1) caused by a mutation in retinitis
pigmentosa (RP) GTPase regulator (RPGR) exon ORF15 showed significant variability in disease onset in
a colony of dogs that all inherited the same mutant X chromosome. Defective protein trafficking has been
detected in XLPRA1 before any discernible degeneration of the photoreceptors. We hypothesized that the
severity of the photoreceptor degeneration in affected dogs may be associated with defects in genes
involved in ciliary trafficking. To this end, we examined six genes as potential disease modifiers. We also
examined the expression levels of 24 genes involved in ciliary trafficking (seven), visual pathway (five),
neuronal maintenance genes (six), and cellular stress response (six) to evaluate their possible
involvement in early stages of the disease.
Methods
Methods: Samples from a pedigree derived from a single XLPRA1-affected male dog outcrossed to
unrelated healthy mix-bred or purebred females were used for immunohistochemistry (IHC), western blot,
mutational and haplotype analysis, and gene expression (GE). Cell-specific markers were used to examine
retinal remodeling in the disease. Single nucleotide polymorphisms (SNPs) spanning the entire RPGR
interacting and protein trafficking genes (RAB8A, RPGRIP1L, CEP290, CC2D2A, DFNB31, and RAB11B)
were genotyped in the pedigree. Quantitative real-time PCR (qRT-PCR) was used to examine the
expression of a total of 24 genes, including the six genes listed.
Results
Results: Examination of cryosections from XLPRA1-affected animals of similar age (3–4 years) with
different disease severity phenotype revealed mislocalization of opsins and upregulation of the Müller cell
gliosis marker GFAP. Four to ten haplotypes per gene were identified in RAB8A, RPGRIP1L, CEP290,
CC2D2A, DFNB31, and RAB11B for further assessment as potential genetic modifiers of XLPRA1. No
correlation was found between the haplotypes and disease severity. During mutational analysis, several
new variants, including a single intronic mutation in RAB8A and three mutations in exon 3 of DFNB31were
described (c.970G>A (V324I), c.978T>C (G326=), and c.985G>A (A329T)). Expression analysis of stress
response genes in 16-week-old predisease XLPRA1 retinas revealed upregulation of GFAP but not HSPA5,
DDIT3, HSPA4, HSP90B1, or HIF1A. Western blot analysis confirmed GFAP upregulation. In the same
predisease group, no significant differences were found in the expression of 18 selected genes (RHO,
OPN1LW, OPN1MW, RLBP1, RPGRORF15, RAB8A, RPGRIP1L, CEP290, CC2D2A, DFNB31, RAB11B, CRX,
RCVRN, PVALB, CALB1, FGFR1, NTRK2, and NTRK3) involved in neuronal function.
Conclusions
Conclusions: Lack of association between haplotypes of RAB8A, RPGRIP1L, CEP290, CC2D2A, DFNB31,
and RAB11B and the disease phenotype suggests that these genes are not genetic modifiers of XLPRA1.
Upregulation of GFAP, an established indicator of the Müller cell gliosis, manifests as an important early
feature of the disease.
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Molecular studies of phenotype variation in canine RPGRXLPRA1
Tatyana Appelbaum, Doreen Becker, Evelyn Santana, Gustavo D. Aguirre
Section of Ophthalmology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA
Purpose: Canine X-linked progressive retinal atrophy 1 (XLPRA1) caused by a mutation in retinitis pigmentosa (RP)
GTPase regulator (RPGR) exon ORF15 showed significant variability in disease onset in a colony of dogs that all inherited the same mutant X chromosome. Defective protein trafficking has been detected in XLPRA1 before any discernible
degeneration of the photoreceptors. We hypothesized that the severity of the photoreceptor degeneration in affected dogs
may be associated with defects in genes involved in ciliary trafficking. To this end, we examined six genes as potential
disease modifiers. We also examined the expression levels of 24 genes involved in ciliary trafficking (seven), visual
pathway (five), neuronal maintenance genes (six), and cellular stress response (six) to evaluate their possible involvement
in early stages of the disease.
Methods: Samples from a pedigree derived from a single XLPRA1-affected male dog outcrossed to unrelated healthy
mix-bred or purebred females were used for immunohistochemistry (IHC), western blot, mutational and haplotype
analysis, and gene expression (GE). Cell-specific markers were used to examine retinal remodeling in the disease.
Single nucleotide polymorphisms (SNPs) spanning the entire RPGR interacting and protein trafficking genes (RAB8A,
RPGRIP1L, CEP290, CC2D2A, DFNB31, and RAB11B) were genotyped in the pedigree. Quantitative real-time PCR
(qRT-PCR) was used to examine the expression of a total of 24 genes, including the six genes listed.
Results: Examination of cryosections from XLPRA1-affected animals of similar age (3–4 years) with different disease severity phenotype revealed mislocalization of opsins and upregulation of the Müller cell gliosis marker GFAP.
Four to ten haplotypes per gene were identified in RAB8A, RPGRIP1L, CEP290, CC2D2A, DFNB31, and RAB11B for
further assessment as potential genetic modifiers of XLPRA1. No correlation was found between the haplotypes and
disease severity. During mutational analysis, several new variants, including a single intronic mutation in RAB8A and
three mutations in exon 3 of DFNB31 were described (c.970G>A (V324I), c.978T>C (G326=), and c.985G>A (A329T)).
Expression analysis of stress response genes in 16-week-old predisease XLPRA1 retinas revealed upregulation of
GFAP but not HSPA5, DDIT3, HSPA4, HSP90B1, or HIF1A. Western blot analysis confirmed GFAP upregulation. In the
same predisease group, no significant differences were found in the expression of 18 selected genes (RHO, OPN1LW,
OPN1MW, RLBP1, RPGRORF15, RAB8A, RPGRIP1L, CEP290, CC2D2A, DFNB31, RAB11B, CRX, RCVRN, PVALB,
CALB1, FGFR1, NTRK2, and NTRK3) involved in neuronal function.
Conclusions: Lack of association between haplotypes of RAB8A, RPGRIP1L, CEP290, CC2D2A, DFNB31, and RAB11B
and the disease phenotype suggests that these genes are not genetic modifiers of XLPRA1. Upregulation of GFAP, an
established indicator of the Müller cell gliosis, manifests as an important early feature of the disease.

The RPGR gene produces multiple alternatively spliced
transcripts, all of which encode an N-terminal RCC1-like
domain that is structurally similar to the RCC1 protein [6],
a guanine nucleotide exchange factor for the Ran GTPase.
One major constitutive isoform spans exons 1 through 19
and carries a C-terminal isoprenylation site. The other major
variant contains exons 1 to 14 and terminates with a large,
alternative ORF15 exon (RPGRorf15) [6-9]. The RPGRorf15
isoform is expressed predominantly in photoreceptor
connecting cilia and basal bodies [10,11] and appears to be
play a critical role in retinal function as multiple diseasecausing mutations have been identified in humans, dogs, and
mice [6,12,13]. Furthermore, gene augmentation therapy with
RPGRorf15 preserves function and prevents degeneration in
these diseases [14,15].

Retinitis pigmentosa (RP) is the clinical rubric for a
large, heterogeneous group of inherited retinal disorders characterized by progressive photoreceptor degenerative disease
leading to vision loss [1]. Of these disorders, X-linked RP
(XLRP) comprises some of the most severe forms of RP and
accounts for approximately 10% to 20% of all RP cases [2,3].
To date, six disease loci (RP2, RP3, RP6, RP23, RP24, and
RP34) on the X chromosome have been mapped (RetNet), and
RP3 accounts for approximately 75% of XLRP cases [4,5].
Retinitis pigmentosa GTPase regulator (RPGR) is the disease
gene of the RP3 locus (RPGR-XLRP) [6,7].
Correspondence to: Gustavo D. Aguirre, School of Veterinary
Medicine, University of Pennsylvania, 3900 Delancey Street,
Philadelphia, PA, 19104; Phone: (215) 898–9426; FAX: (215) 573–
6050; email: gda@vet.upenn.edu
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To date, the X-linked progressive retinal atrophy
(XLPRA) dog is the only known naturally occurring large
animal model of RPGR mutations [12]. The canine XLPRA
phenotype has been linked to RPGR, and homology of canine
XLPRA and human RP3 has been established [16,17]. Two
disease-causing microdeletion mutations in exon ORF15 have
been identified in canine RPGR [12]. One produces a premature stop (del1028–1032) resulting in a C-terminal truncation
of 230 residues in XLPRA1. The second is a 2 nt deletion
(del1084–1085) that causes a frameshift with the inclusion
of 34 basic amino acids and truncation of the terminal 161
residues and is causal for XLPRA2. The phenotype associated with the frameshift mutation in XLPRA2 is severe and
consistent, and manifests during retinal development; the
phenotype resulting from XLPRA1 is expressed only after
normal photoreceptor morphogenesis has been completed and
has more gradual progression [12].

We expanded the analysis of genetic modifiers of XLPRA1
to include genes that encode RPGR-interacting proteins
(RPGRIP1L [25,31], DFNB31 [32], and RAB8A [33]) and
proteins essential for cilia formation, ciliary trafficking, and
cargo delivery (CEP290 [9], RAB11B [34], and CC2D2A
[35]). We also examined the expression of 24 genes involved
in ciliary trafficking, visual pathway, neuronal maintenance,
and cellular stress response to evaluate their possible involvement in early stages of XPLRA1 disease.

Extensive phenotypic diversity is observed in patients
with RPGR mutations, between patients with different
mutations, and between patients within families who have
the same mutation [18-20]. Dogs with XLPRA1 also show
remarkable phenotypic variability in clinical cases and,
more surprisingly, within a closed research colony where
all dogs are maintained in a constant environment, exposed
to the same light intensities and cycles, and fed a uniform
diet [21,22]. Such phenotypic variability cannot be simply
explained by heterogeneity at the primary locus since all
affected dogs inherited the same single mutant X chromosome, and the mutation is stably present through multiple
generations [12,21]. Since genetic modifiers can alter the
course of diseases, including RPGR-XLRP [18,23-25], we
hypothesized that a modifier gene or genes contribute to the
phenotypic variability observed in XLPRA1. Previously, we
analyzed six genes (RPGRIP1, RANBP2, NPM1, PDE6D,
NPHP5, and ABCA4) as genetic modifiers of XLPRA1 but
excluded all [22]. As studies on RPGR-interacting proteins
and those in the RPGRKO model suggest that RPGR functions in ciliary trafficking [9,26], here we focused on modifier
genes that might also affect ciliary transport, thus potentiating
the opsin mislocalization that contributes to XLPRA1 [27].
Candidate gene modifiers of XLPRA1 were chosen based on
their contribution to ciliary formation, vesicular transport,
and rod outer segment disc formation [28].

Pedigree resources and determination of the phenotypic
status: Details of the origin and composition of the colony
have been previously published [21,22,36]. Briefly, the colony
was established by outcrossing a single XLPRA1-affected
male Siberian husky to unrelated healthy female beagles
shown to be free from inherited retinal degeneration based
on test breeding to known homozygous affected dogs with
other autosomal recessive diseases [37]. The carrier progeny
were subsequently mated with mixed breed or purebred dogs
of varied genetic background to produce informative hemizygous or homozygous affected males or females, respectively,
and heterozygous females. All dogs were maintained under
specific and standard conditions where all animals have the
same exposure to cyclic light (12 h:12 h light-dark cycle),
receive the same diet, and have the same medical procedures
and vaccinations. A subset of the colony, consisting of 43
dogs (affected with the RPGR mutation (n = 24), carriers
(n = 7), and healthy (n = 12)), was selected for the studies
(Appendix 1). The dogs in the study were the same used in
a prior analysis of potential candidate gene disease modifiers [22]. Dogs were included based on the results of serial
clinical assessment of retinal disease status using indirect
ophthalmoscopy and electroretinography (ERG). Morphologic criteria were used to establish grades of disease severity
taking into account the animal’s age and the degree and extent
of disease [21]. Three grades were defined: Mild degeneration present only in periphery after 1.5 years of age or later,
Moderate degeneration present only degeneration develops
between 11 and 15 months of age, and Severe (photoreceptor
degeneration stage 2 or more advanced, present centrally and
peripherally) [21]. Of the 24 affected dogs (22 hemizygous
males and two homozygous females), 14 were classified as

In the present study, we characterized retinas from
XLPRA1 dogs with different degrees of disease for the
expression of opsins and the Müller cell marker glial fibrillary acidic protein (GFAP), which responds to outer retinal
stress and is one of the earliest genes upregulated in several
non-allelic forms of inherited retinal degeneration [29,30].

METHODS
Ethics statement: The research was conducted in full compliance and strict accordance with the Association for Research
in Vision and Ophthalmology (ARVO) Resolution on the Use
of Animals in Ophthalmic and Vision Research. The protocol
was approved by the University of Pennsylvania Institutional
Animal Care and Use Committee (IACUC).
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Severe, nine as Moderate, and one as Mild. The skewed
phenotype distribution results from selective breeding to
produce affected dogs that could be diagnosed at an early
age to be ascertained for the linkage mapping and gene and
mutation identification studies [12,17]. As the group of dogs
with Mild disease contained only one dog, in the diseaseassociation studies only those with Moderate and Severe
disease were used for analysis.
Sample collection, DNA/RNA extraction, and cDNA
synthesis: Retinas were collected from enucleated eyes under
sterile and RNase-free conditions, frozen by immersion in
liquid nitrogen, and stored at -70 °C until used. For terminal
procedures, the dogs were anesthetized by intravenous injection of pentobarbital sodium (65 mg/ml solution was prepared
under sterile conditions by the Penn Medicine Investigational
Drug Service), the eyes enucleated, and the dogs immediately
euthanatized with intravenous Euthasol (Virbac, Ft. Worth,
TX). Total RNA was isolated from canine tissues using a
modified TRIzol and single chloroform extraction protocol.
Briefly, 1 ml of TRIzol (Invitrogen, Carlsbad, CA) was added
to the retina, and 0.2 ml of chloroform (Sigma-Aldrich, Allentown, PA) was added after tissue homogenization; the tissueTrizol-chloroform mix then was centrifuged at 1,484 ×g at 4
°C for 4 min. The clear aqueous upper phase was transferred
to a fresh microfuge tube and mixed to 70% ethanol (1:1,
V/V). Next, the sample was loaded on an RNeasy Mini spin
column, and the RNA was further purified using an RNeasy
kit (Qiagen, Valencia, CA) following the manufacturer’s
directions. First-strand cDNA was synthesized in 20 μl reactions using the High Capacity RNA-to-cDNA kit (Applied
Biosystems, Foster City, CA) following the manufacturer’s
recommendations. Genomic DNA was isolated from blood
samples using the QIAamp DNA kit (Qiagen) following the
manufacturer’s directions.
Genotype and haplotype analysis within candidate genes:
Six genes were chosen for analysis (RAB8A, RPGRIP1L,
CEP290, CC2D2A, DFNB31, and RAB11B). Polymorphic
sites consisting of SNPs were identified in selected genes
based on the Broad Institute SNP database, the Dog Genome
SNP Database, and SNP database or based on our own gene
sequencing analyses. Genotyping was performed using direct
sequencing of PCR products. PHASE software (v. 2.1.1) was
used for haplotype reconstruction. Fisher’s exact test (twosided) was used for statistical analysis (p≤0.05). For this
analysis, we posited that a candidate gene modifier would
have a homozygous haplotype in dogs with Severe phenotype
and heterozygous in those with a Moderate phenotype.
PCR amplification and sequencing: Primer sequences for the
PCR experiments are shown in Appendix 2. PCR reactions

© 2016 Molecular Vision

were performed on 50 ng genomic DNA in a final volume
of 25 μl containing 2x PCR master Mix (New England
Biolabs, Ipswich, MA), 0.7 μM forward and reverse primers,
and PCR-grade water. Cycling conditions were 2 min initial
denaturation at 95 °C followed by 35 cycles of 95 °C for 20
s (denaturation), 52 °C for 30 s (annealing), and 68 °C for
30 s (elongation). For sequencing purposes, the PCR products were analyzed on a 2% agarose gel, extracted with the
NucleoTrap Gel Extraction Kit (Clontech, Mountain View,
CA), and directly sequenced.
Relative quantification (ddCt) assay: Real-time PCR was
performed in a total volume of 20 μl in 96-well microwell
plates on the Applied Biosystems 7500 Real-Time PCR
System. All PCRs were performed using cDNA generated
from 15 ng DNase-treated RNA from 16-week-old healthy
retinas (n = 3) and XLPRA1-affected dogs (n = 6). The SYBR
Green platform was used for gene expression analysis of 24
genes using a primer concentration of 0.2 μM. The primer
sequences for real-time PCR are listed in Appendix 3.
The TBP gene expression level was used to normalize the
cDNA templates. Amplification data were analyzed with the
7500 Software version 2.0.1 (Applied Biosystems). Genes
included for this analysis coded for proteins essential for
cilia formation, ciliary trafficking, and cargo delivery, and
genes involved in ciliary formation, visual pathway, neuronal
maintenance, and cellular stress response; the genes are listed
in Table 1.
Fluorescent immunohistochemistry: Retina from three
XLPRA1-affected dogs and a healthy dog was used for
immunohistochemistry (IHC). These dogs are not part of the
genetic modifier pedigree. The procedures used for tissue
collection, preparation, and sectioning have been previously
described [38]. Cryosections were washed and treated with
the primary antibodies in PBS solution (1X; 137 mM NaCl,
2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4), 3%
normal horse serum (NHS, Vector Laboratories, Burlingame,
CA), 1% bovine serum albumin (BSA, Sigma-Aldrich) and
0.3% Triton X-100 (Sigma-Aldrich) overnight followed by
incubation with appropriate fluorescent secondary antibodies
(Alexa Fluor Dyes, 1:300; Molecular Probes, Eugene, OR).
The following primary antibodies were used in the study:
mouse anti-rhodopsin at 1:1,000 (MAB5316, Chemicon,
Temecula, CA), rabbit anti-L/M opsin at 1:1,000 (AB5405,
Millipore, Billerica, MA), goat anti-hCAR (human cone
arrestin) at 1:1,000 (a gift from Dr. W. Beltran, University
of Pennsylvania), and rabbit anti-GFAP at 1:1,000 (Z0334,
Dako, Carpinteria, CA). 4’, 6-diamidino-2-phenylindole
(DAPI, Sigma-Aldrich) stain was used to label the cell nuclei.
Slides were mounted with fluoromount G mounting media
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(catalog No. 01100-01; Southern Biotech, Birmingham, AL),
coverslipped, and examined with epifluorescence microscopy
with a Zeiss Axioplan microscope (Carl Zeiss Meditech,
Oberkochen, Germany). Images were digitally captured (Spot
4.0 camera; Diagnostic Instruments, Inc., Sterling Heights,
MI) and imported into a graphics program (Photoshop;
Adobe, Mountain View, CA) for display.

© 2016 Molecular Vision

System (Bio-Rad) and blocked for 1 h at room temperature or overnight at 4 °C with 1× Odyssey Blocking Buffer
(LI-COR). Immunoblots were probed overnight at 4 °C with
unconjugated primary antibodies diluted in 1× Blocking
Buffer. Membranes were then washed 3X with PBST (PBS
containing 0.1% Tween 20 (Sigma-Aldrich) and incubated for
1 h at room temperature in goat anti-rabbit IRDye680RD- and
goat anti-mouse IRDye800CW-conjugated immunoglobulin
G (IgG) secondary antibodies (LI-COR) diluted 1/10,000
each in 1× Blocking Buffer containing 0.1% Tween-20.
Immunoblots were washed three times in PBST, once in PBS,
and scanned on the Li-COR Odyssey Fc Dual-Mode Imaging
System with 700- and 800-nm channels. Normalization to
ACTB and analyses were done using Image Studio Software
provided by LI-COR. The primary antibodies used were
rabbit anti-GFAP at 1:5,000 (Z0334, Dako) and anti-mouse
ACTB at 1:10,000 (MAB1501, Millipore). Quantification of
the proteins on western blot was performed with Li-COR
Odyssey software.

Western blot analysis: Western blotting was performed with
multiplex infrared detection using secondary antibodies
conjugated to IRDye® fluorescent dyes. Briefly, total protein
extracts in equal amounts (50 µg) as determined with the
BCA Protein Assay Kit (Thermo Fisher Scientific, Rockford, IL) were resolved using 4–15% acrylamide gradient
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE gel; Bio-Rad Laboratories, Hercules, CA) in
Tris/glycine/SDS buffer (BioRad). Resolved proteins were
immunoblotted into nitrocellulose membranes (LI-COR
Biosciences, Lincoln, NE) using the Wet/Tank Blotting

Table 1. RNA expression changes of retinal genes in 16 week old XLPRA1 retinas.
Gene

Gene name

FC* XLPRA1 versus normal retina

RHO

rhodopsin

n.s.**

OPN1LW

opsin 1 (cone pigments), long-wave-sensitive

n.s.

OPN1MW

opsin 1 (cone pigments), medium-wave-sensitive

n.s.

RLBP1

retinaldehyde binding protein 1

n.s.

RPGRORF15

retinitis pigmentosa GTPase regulator

n.s.

RAB8A

RAB8A, member RAS oncogene family

n.s.

RPGRIP1L

RPGRIP1-like

n.s.

CEP290

centrosomal protein 290 kDa

n.s.

CC2D2A

coiled-coil and C2 domain containing 2A

n.s.

DFNB31

deafness, autosomal recessive 31

n.s.

RAB11B

RAB11B, member RAS oncogene family

n.s.

CRX

cone-rod homeobox

n.s.

RCVRN

recoverin

n.s.

PVALB

parvalbumin

n.s.

CALB1

calbindin 1

n.s.

FGFR1

fibroblast growth factor receptor 1

n.s.

NTRK2

neurotrophic tyrosine kinase, receptor, type 2

n.s.

NTRK3

neurotrophic tyrosine kinase, receptor, type 3

n.s.

GFAP

glial fibrillary acidic protein

6.7

HSPA5

heat shock 70 kDa protein 5

n.s.

DDIT3

DNA-damage-inducible transcript 3

n.s.

HSPA4

heat shock 70 kDa protein 4

n.s.

HSP90B1

heat shock protein 90 kDa beta

n.s.

HIF1A

hypoxia inducible factor 1, alpha subunit

n.s.

*FC=fold change differences ** n.s.=non statistically significant differences
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Figure 1. XLPRA1-affected retina: immunohistochemical characterization of different severity phenotypes. A–D: Hematoxylin and eosin
(H&E)–stained retinal cryosections from the superior quadrant (6,000 μm from the ora serrata; area is approximately the midpoint between
the disc and the ora serrata) in dogs of comparable ages that have different phenotype severity. E–H: Double immunolabeling with RHO and
GFAP antibodies. I–L: Double immunolabeling with hCAR and M/L opsin antibodies. Where appropriate (E, F, I, J), the immunolabeling
images show the individual blue, green, and red channels with the merged image on the right of each set to show the mislocalization of opsin
(*). RPE= retinal pigment epithelium; PR = photoreceptors; ONL = outer nuclear layer; OPL = outer plexiform layer; INL = inner nuclear
layer; IPL = inner plexiform layer; GCL= ganglion cells layer.

RESULTS
Characterization of XLPRA1-affected dogs with different
severity phenotype: Examination of hematoxylin and eosin
(H&E)-stained cryosections from XLPRA1-affected dogs of
comparable ages (3–4 years) showed morphological alterations compatible with an ongoing disease process (Figure
1A–D). Disease was accompanied by decreased rod density
and outer nuclear layer (ONL) thickness. Significant photoreceptor loss (ONL = 1 row) was observed in the youngest
animal with Severe phenotype. To evaluate the localization of
photoreceptor-specific proteins, double immunolabeling and
DAPI nuclear staining were performed in the affected dogs.
Immunolabeling with rod opsin showed mislocalization in
Mild disease and loss of rods in Moderate and Severe disease.
GFAP was upregulated in all disease phenotypes and was
mostly present in the inner plexiform layer (IPL) and to a
lesser extent in the outer plexiform layer (OPL; Figure 1E–H);
increased GFAP expression was more prominent in Moderate

and Severe disease. Double immunolabeling with hCAR and
M/L opsin antibodies showed cone outer segment disorganization and mislocalization of M/L cone opsin (Figure 1I–L),
and disorganization and loss of the outer segments (OS) were
observed in the remaining rods and cones.
Genotype-phenotype analysis in XLPRA1 pedigree: As
demonstrated previously [27] and in the present study (Figure
1), XLPRA1 is characterized by defective protein trafficking
that leads to mislocalization of opsins to the inner segment,
nuclear, and synaptic layers. Thus, the presence of mutations
that perturb protein trafficking could have severe functional
consequences that could result in photoreceptor cell death. To
this end, six genes (RAB8A, RPGRIP1L, CEP290, CC2D2A,
DFNB31, and RAB11B) were investigated as candidate disease
modifiers. The proteins encoded by these genes are involved
in common and distinct pathways required for effective
protein trafficking in cilia and cargo delivery, and some
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(RPGRIP1L, DFNB31, and RAB8A) directly interact with
RPGR.
Profiling sequence changes in RAB8A, RPGRIP1L, CEP290,
CC2D2A, DFNB31, and RAB11B genes: Polymorphic markers
were identified by sequence analysis of randomly selected
regions within the genes of interest in the XLPRA1-affected
study dogs. In addition, details of SNPs from several public
SNP databases used for genotype and haplotype analysis are
presented in Appendix 2. As two mutations in RPGRIP1L
(A229T and R744Q) have been previously shown to contribute
to phenotypic variability in retinal degeneration [18,25], we
first analyzed the affected RPGR mutant dogs for the presence of A229T and R744Q. Human and canine RPGRIP1L is
predicted to have 90.0% amino acid sequencing homology
(compare NM_015272 and XP_013964947); therefore, A229
and R744 are in the same position in the human and canine
RPGRIP1L sequence. None of the dogs analyzed harbored
either mutation.
Sequence analysis of other genes identified four new
variants: a single intronic change in RAB8A and three in
exon 3 of DFNB31 in affected dogs. Sequence changes in
DFNB31 exon 3 include two missense [(c.970G>A (p.V324I)
and (c.985G>A (p.A329T))] and one synonymous (c.978T>C
(p.G326=)) change (Figure 2). We performed alignment of the
DFNB31 orthologous sequences to see whether the missense
mutations affected conservative amino acid residues (Figure
3). Analysis of the corresponding protein region in multiple
species has identified valine and isoleucine in position 324 of
DFNB31; thus, it is unlikely that the V324I missense change
observed in canine DFNB31 is consequential. However, the
canine sequence has alanine at position 329 of DFNB31 while
all other analyzed orthologous sequences contain proline.
Although alanine and proline are hydrophobic neutral amino
acids, the A329T change found in DFNB31 replaces alanine
with threonine, a polar and hydrophilic residue that could
potentially affect the structure and function of the protein.
However, A329T was not included in the genotype and haplotype analysis as A329T was present only in the founder (H2)
that was a carrier for the mutation.
The DFNB31 variants (V324I and G326=) were
frequently present in the XLPRA1-affected dogs of the
pedigree, but neither was associated with disease phenotype
(Appendix 4). Despite a high prevalence of V324I (69.6% of
XLPRA1-affected dogs), this variant appeared to have been
artificially accumulated in the pedigree as the founder (H2),
and most females used for breeding harbored V324I and
passed it on to their offspring. Therefore, we concluded that
the V324I sequence change is unlikely to have any functional
consequences.

© 2016 Molecular Vision

Genotype distribution: Genotype frequencies for the SNPs
abundant in the XLPRA1-affected dogs are shown in
Appendix 4 and were compared for the Moderate and Severe
phenotypes. The genotype distributions of all analyzed SNPs
were not statistically different between these two groups.
Haplotype distribution: The polymorphic SNPs in Appendix
2 provide the basis for gene-specific haplotype association
studies. These results are presented in Table 2 and Table
3. The number of haplotypes per gene varied from four
(CEP290) to ten (DFNB31; Table 2). Next, we compared
the frequencies of haplotypes in the Moderate and Severe
phenotypes of XLPRA1-affected dogs (Table 3). The haplotype frequencies for the genes RAB8A, RPGRIP1L, CEP290,
CC2D2A, DFNB31, and RAB11B were not statistically
different between the two groups analyzed in this study, thus
excluding all six genes as candidate modifiers of the disease
phenotype observed in the XLPRA1 pedigree.
Gene expression of selected genes in the study model: Variations in gene expression can also be associated with disease
[39,40], and the lack of gene expression data for components
of the RPGR molecular network hinders our understanding
of its role in phenotypic expression of XLPRA1. In this
study, we examined the expression of RPGRORF15, RAB8A,
RPGRIP1L, CEP290, CC2D2A, DFNB31, and RAB11B in six
XLPRA1-affected predisease (16 week old) retinas to determine whether expression changes in gene expression might
contribute to disease progression. To gain more in-depth
understanding of the disease-induced changes in gene expression, we also examined the expression of selected genes
involved in the visual pathway (RHO, OPN1LW, OPN1MW,
and RLBP1), neuronal cells (CRX, RCVRN, PVALB, CALB1,
FGFR1, NTRK2, and NTRK3), and cellular stress response
(GFAP, HSPA5, DDIT3, HSPA4, HSP90B1, and HIF1).
Out of the total 24 genes examined, only GFAP gene
expression was upregulated (6.7-fold increase) in all XLPRA1
animals compared to the control group (p<0.01, Table 1). The
GFAP level in XLPRA1 in the predisease samples was highly
variable and increased in expression early in other retinal
degeneration disorders in dogs [29,30]. The estimated variance in the XLPRA1 group was 9.96 compared to variance
of only 0.07 in the control group. Upregulation of the GFAP
protein in the 16-week-old XLPRA1 retinas was confirmed
with western blot analysis (Figure 4).
DISCUSSION
RPGR is an important component of the ciliary protein
network, but details of the molecular function of RPGR
in photoreceptors cilia are still incomplete. The protein
complexes in which RPGR participates in the ciliary
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Molecular Vision 2016; 22:319-331 <http://www.molvis.org/molvis/v22/319>

compartment play key roles in the function and maintenance
of photoreceptor cells. For example, RPGR is associated
through NPHP1, NPHP5, RPGRIP1, RPGRIP1L, RAB8A,
CEP290, and SMC1/3 with the nephrocystin protein network
and ciliary transport [9,41-44], through DFNB31 to the Usher
protein network [32], and through NPM1 to the centrosomal
protein network [45]. Defects of proteins in these complexes
lead to photoreceptor dysfunction, cell death, and retinal
degeneration.
The mislocalization of opsin is thought to contribute
to the pathophysiology of photoreceptor degeneration.
Changes in opsin localization have been reported for many
diseases and injuries where photoreceptor cell death occurs,
including human and animal models of retinal degeneration
[13,27,46,47]. Opsin mislocalization is a feature of XLPRA1

© 2016 Molecular Vision

and XLPRA2 and other canine retinal degeneration disorders
(Figure 1 and [27,30,48]). Similar to several other RPGR
disease models [13,49], opsin mislocalization was detected in
XLPRA1 before any discernible photoreceptor degeneration.
Since mutations in ciliary trafficking genes can contribute
to ciliary transport defects, six genes (RAB8A, RPGRIP1L,
CEP290, CC2D2A, DFNB31, and RAB11B) were selected
based on their interaction with RPGR or involvement in
ciliary transport and investigated as candidate genetic modifiers of XLPRA1.
The XLPRA1 pedigree is small, and its inbred affected
population is not ideal for linkage disequilibrium (LD)
analysis. Because of these limitations, we compared genespecific genotypes and haplotypes frequencies in Severe
versus Moderate affected dogs to determine whether there

Figure 2. Chromatograms showing
the variants detected in the canine
DFNB31 gene (exon 3). c.970G>A
and c.985G>A result in a substitution of valine for isoleucine at
position 324 and alanine for threonine at position 329 of DFNB31,
respectively (top). c.978T>C does
not result in a change in the amino
acid sequence (bottom). In both
chromatograms, the relevant area
is marked with an arrow.
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Figure 3. Multiple alignment of the
DFNB31 orthologous sequences.
The alignment shows that vertebrate DFNB31 orthologs have either
valine or isoleucine (marked by a
single asterisk) in the protein region
corresponding to position 324 of
the canine DFNB31 and proline or
alanine (marked by double asterisks) at position 329.

was a putative correlation between genotype or haplotype and
disease phenotype. By carrying out this strategy, we found
that moderately and severely affected dogs had no differences in genotypes and haplotype frequencies for RAB8A,
RPGRIP1L, CEP290, CC2D2A, DFNB31, and RAB11B.
Furthermore, these six genes were not variably expressed in

predisease XLPRA1 retinas suggesting that the gene products
do not serve as modifiers of disease phenotype.
During mutational analysis, three novel sequence
variants were discovered in DFNB31 (V324I, G326, and
A329T). All three were located in exon 3, which encodes
part of the PDZ2 domain responsible for binding to the
C-terminal of RPGRorf15 [32]. V324I was present in 69.6% of

Table 2. H aplotypes reconstructed in the XLPRA1 pedigree.
Gene

Haplotype

RAB8A

1

2

3

4

5

6

chr20:46336246

C

C

C

C

C

C

Gene

Haplotype

7

CC2D2A

1

2

3

4

5

6

7

A

chr3:64841219

A

A

A

A

T

T

T

46344912

C

C

C

C

G

G

G

64854752

C

G

T

T

C

C

C

46349143

T

T

C

C

T

C

T

64859223

G

T

C

T

G

T

T

46351756

G

A

G

A

G

G

G

64861317

A

A

A

A

G

A

G

RPGRIP1L

1

2

3

4

5

6

DFNB31

1

2

3

4

5

6

7

8

9

10

chr2:62092489

C

C

C

G

G

G

chr11:68620384

A

A

A

A

A

G

G

G

G

G

62122046

A

A

A

T

T

T

68642086

T

T

T

G

G

T

T

T

T

T

62138129

A

A

C

A

A

A

68658508

A

A

A

A

A

G

G

G

G

G

62152007

G

G

G

G

A

A

68671284

T

T

C

T

T

T

T

C

C

C

62163783

C

T

T

T

C

T

68671292

G

A

G

A

A

G

G

G

G

G

62166939

C

C

C

T

T

T

68680635

A

G

A

G

G

G

A

G

G

A

68698265

C

C

C

C

G

G

C

C

G

C

CEP290

1

2

3

4

RAB11B

1

2

3

4

5

6

7

chr15:29199693

G

G

G

C

chr20:52957965

C

C

C

C

G

C

A

29220545

G

G

A

A

52960719

C

C

C

C

C

G

G

29228039

T

T

C

C

52963299

T

T

C

C

T

C

T

29247843

A

G

A

A

52965822

G

A

G

A

G

G

G

29265700

T

T

C

C

29279083

G

G

A

A
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Figure 4. Representative western
blot analysis for GFAP on two
XLPR A1-affected retinas (S1
and S2, 16 weeks) versus the
age-matched healthy retina (16
weeks). Quantification of proteins
on western blot performed with
Li-COR Odyssey software showed
upregulation of GFAP in S1 and
S2 retinas of 2.3 and 2.5 times,
respectively.

XLPRA1-affected dogs, suggesting at first that it could be
associated with disease. However, on closer examination we

found that this mutation artificially accumulated in the

Table 3. H aplotypes distribution in XLPRA1 affected dogs with different severity phenotype.
Sample ID

RAB8A

RPGRIP1L

CEP290

CC2D2A

DFNB31

RAB11B

Severe

H2

1,2

1,2

1,1

1,2

1,4

1,2

H64

3,4

2,2

2,4

2,3

4,10

3,4

H104

3,5

3,6

2,2

2,3

6,6

3,5

H105

5,5

2,2

2,2

3,7

2,6

5,5

H78

5,5

2,5

2,3

7,7

4,10

5,5

H79

1,5

2,5

2,3

7,7

2,9

1,5

H82

1,5

2,5

1,2

2,7

2,9

1,5

H143

5,7

4,5

1,2

2,6

6,10

5,7

H35

3,5

2,5

3,4

2,2

3,3

3,5

H38

3,7

2,5

1,4

2,2

6,7

1,6

H71

2,3

3,5

1,4

1,1

4,10

2,3

H72

6,7

2,5

1,2

2,7

4,10

6,7

H73

2,5

3,5

1,2

1,1

5,10

2,5

H118

3,7

5,5

2,4

2,2

6,10

3,7

Moderate
H29

5,5

3,6

2.3

3,7

4,9

5,5

H31

5,5

3,5

1,3

1,5

4,10

5,5

H130

3,3

2,5

1,2

2,2

2,6

3,3

H131

3,3

2,5

2,4

4,4

4,6

3,3

H81

5,5

3,3

1,3

5,5

4,4

5,5

H208

2,5

2,4

2,2

2,7

2,6

2,5

H59

4,7

2,5

2,3

2,3

9,10

4,7

H201

2,5

5,5

1,1

2,3

8,10

2,5

H202

3,7

5,5

1,2

3,3

2,9

3,7
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pedigree. Additional analysis of DFNB31 orthologous
sequences excluded a putative harmful effect of V324I.
In addition to the seven genes involved in protein
trafficking (RPGRORF15, RAB8A, RPGRIP1L, CEP290,
CC2D2A, DFNB31, and RAB11B), we analyzed the expression of a subset of genes necessary for the visual pathway
(RHO, OPN1LW, OPN1MW, and RLBP1), neuronal cell maintenance (CRX, RCVRN, PVALB, CALB1, FGFR1, NTRK2,
and NTRK3), molecular chaperons (HSPA4, HSP90B1),
unfolded protein response (HSPA5, DDIT3), cellular
response to hypoxia (HIF1), and Müller cell gliosis (GFAP)
in early XLPRA1. Although opsins are mislocalized in early
XLPRA1 [27], we found that their gene expression was not
impaired in 16-week-old predegenerate retinas. Aside from
GFAP, other genes were not differentially expressed. Notably,
GFAP expression was already upregulated at 16 weeks of age,
when the XLPRA1 retinas are morphologically normal [21].
GFAP expression in Müller cells in the mammalian retina is
normally low but is upregulated in a variety of degenerative
conditions, including retinal trauma, diabetic retinopathy
[50], choroidal neovascularization [51], retinal detachment
[52], glaucoma [53], and age-related macular degeneration
[54].
The results obtained in this study clearly demonstrate that
even when mutated retinas appear morphologically normal,
the Müller cells respond with a dramatic increase in GFAP
expression in the early phase of XLPRA1. We also identified GFAP as highly variable in expression across predisease
XLPRA1 retinas. Could GFAP gene expression variability
lead to or be a marker of phenotypic diversity of XLPRA1? It
is possible. Recent publications describe a complex interplay
between Müller cells and retinal microglia in pathological
conditions [55,56] that mediate adaptive responses within the
retina and may be relevant to amplifying and coordinating
an inflammatory response. The severity of the photoreceptor
degeneration in XLPRA1-affected dogs may be associated
with increased retinal inflammation. Therefore, an inflammatory response in the XLPRA1 retina should be further
investigated.
GFAP typically increases with disease progression but
decreases in some models in advanced stages of degeneration [27,57]. When assessing retinal remodeling events in
XLPRA1-affected dogs with different severity phenotype, we
observed markedly higher levels of GFAP in all disease stages
in comparison to the healthy retina (Figure 1E–H). In addition, GFAP immunolabeling showed Müller glia reactivity
increased with severity of the disease. This increase could
be a sign of a sustained disturbance in retinal homeostasis
in the disease.

© 2016 Molecular Vision

In conclusion, this study reports a lack of association between the RAB8A, RPGRIP1L, CEP290, CC2D2A,
DFNB31, and RAB11B genes and disease severity phenotype
in canine XLPRA1. Selected genes responsible for neuronal
cell maintenance and cellular stress response were not differentially expressed in predisease retinas except GFAP, which
appears to be as an important early feature of the disease.
Current perspectives on the genetic analysis of canine
XLPRA1: The search for potential genetic modifier(s) of the
XLPRA1 phenotype will continue. As the next step, we will
conduct a genome-wide scan in the XLPRA1-affected pedigree to search for loci associated with the disease phenotype.
APPENDIX 1. XLPRA1 PEDIGREE.
To access the data, click or select the words “Appendix 1.”
H2 is a Siberian husky founder that was outcrossed to dogs
from various breeds. The following abbreviations were used:
(B) beagle, (N) mixed breed control, and (E) Norwegian
elkhound-derived outcross. Severely affected dogs are in
black, moderately affected dogs in dark gray, and mildly
affected dogs in crosshatch pattern. Squares represent male
and circles represent female. Dotted circles are carrier females
that were not included in the phenotype analysis. (Figure was
modified from our previously published article [22]).
APPENDIX 2. CHARACTERISTICS OF THE SNP
MARKER PANEL AND ASSOCIATED PCR PRIMERS
SEQUENCES
To access the data, click or select the words “Appendix 2.”
Note: *SNP positions are given according to UCSC Genome
Browser on Dog May 2011 (Broad/canFam3) assembly; **
Mutation position in the protein
APPENDIX 3. REAL-TIME PCR PRIMERS USED IN
THE STUDY.
To access the data, click or select the words “Appendix 3.”
APPENDIX 4. GENOTYPE FREQUENCIES IN
XLPRA1 AFFECTED DOGS WITH DIFFERENT
SEVERITY PHENOTYPES.
To access the data, click or select the words “Appendix 4.”
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